Literature DB >> 14501797

Microbicides and HIV: help or hindrance?

Eran Karmon1, Malcolm Potts, Wayne M Getz.   

Abstract

We present a simple mathematical model for assessing the effects of introducing a microbicide as an HIV infection protective method. As very little is known about the in vivo efficacy of microbicides, we ran sample scenarios for microbicides of various efficacies. We found that, in general, if existing condom usage in a community is low, introducing a microbicide will most likely have a positive impact on HIV incidence as abandonment of condom use in favor of microbicides will not play a significant role. If condom use in a community is high, though, attrition of condom users could play a role large enough to overwhelm any added risk reduction afforded new microbicide users. Our model illustrates the importance of knowing key behavioral parameters, such as the proportion of the population that uses condoms, before microbicides can be safely introduced. These parameters include the proportion of condom users likely to maintain condom use and the proportion of condom nonusers likely to adopt microbicides, as well as the efficacy of the candidate microbicide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501797     DOI: 10.1097/00126334-200309010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Sex-structured HIV/AIDS model to analyse the effects of condom use with application to Zimbabwe.

Authors:  Z Mukandavire; W Garira
Journal:  J Math Biol       Date:  2007-01-11       Impact factor: 2.259

2.  The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.

Authors:  Marie-Claude Boily; Dobromir Dimitrov; Salim S Abdool Karim; Benoît Mâsse
Journal:  Sex Transm Infect       Date:  2011-12       Impact factor: 3.519

3.  Context of Acceptability of Topical Microbicides: Sexual Relationships.

Authors:  Helen P Koo; Cynthia Woodsong; Barbara T Dalberth; Meera Viswanathan; Ashley Simons-Rudolph
Journal:  J Soc Issues       Date:  2005-03

4.  Potential impact of vaginal microbicides on HIV risk among women with primary heterosexual partners.

Authors:  James M McMahon; Kathleen M Morrow; Margaret Weeks; Dianne Morrison-Beedy; Amanda Coyle
Journal:  J Assoc Nurses AIDS Care       Date:  2010-06-18       Impact factor: 1.354

5.  Impact of Pill Sharing on Drug Resistance Due to a Wide-Scale Oral Prep Intervention in Generalized Epidemics.

Authors:  Dobromir Dimitrov; Marie-Claude Boily; Benoît R Mâsse; Elizabeth R Brown
Journal:  J AIDS Clin Res       Date:  2012-07-08

6.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

7.  Pre-exposure prophylaxis in Southern Africa: feasible or not?

Authors:  Willem Daniel François Venter; Frances Cowan; Vivian Black; Kevin Rebe; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

8.  When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study.

Authors:  Hannah Grant; Zindoga Mukandavire; Robyn Eakle; Holly Prudden; Gabriela B Gomez; Helen Rees; Charlotte Watts
Journal:  J Int AIDS Soc       Date:  2017-09-20       Impact factor: 5.396

9.  Prospects for HIV control in South Africa: a model-based analysis.

Authors:  Leigh F Johnson; Calvin Chiu; Landon Myer; Mary-Ann Davies; Rob E Dorrington; Linda-Gail Bekker; Andrew Boulle; Gesine Meyer-Rath
Journal:  Glob Health Action       Date:  2016-06-08       Impact factor: 2.640

Review 10.  Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.

Authors:  Dobromir Dimitrov; Marie-Claude Boily; Elizabeth R Brown; Timothy B Hallett
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.